Cargando…

Expanding applications of MRI-based radiomics in HER2-positive breast cancer

Detalles Bibliográficos
Autor principal: Park, Vivian Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578668/
https://www.ncbi.nlm.nih.gov/pubmed/33096473
http://dx.doi.org/10.1016/j.ebiom.2020.103085
_version_ 1783598416796844032
author Park, Vivian Y.
author_facet Park, Vivian Y.
author_sort Park, Vivian Y.
collection PubMed
description
format Online
Article
Text
id pubmed-7578668
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-75786682020-10-23 Expanding applications of MRI-based radiomics in HER2-positive breast cancer Park, Vivian Y. EBioMedicine Commentary Elsevier 2020-10-20 /pmc/articles/PMC7578668/ /pubmed/33096473 http://dx.doi.org/10.1016/j.ebiom.2020.103085 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Park, Vivian Y.
Expanding applications of MRI-based radiomics in HER2-positive breast cancer
title Expanding applications of MRI-based radiomics in HER2-positive breast cancer
title_full Expanding applications of MRI-based radiomics in HER2-positive breast cancer
title_fullStr Expanding applications of MRI-based radiomics in HER2-positive breast cancer
title_full_unstemmed Expanding applications of MRI-based radiomics in HER2-positive breast cancer
title_short Expanding applications of MRI-based radiomics in HER2-positive breast cancer
title_sort expanding applications of mri-based radiomics in her2-positive breast cancer
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578668/
https://www.ncbi.nlm.nih.gov/pubmed/33096473
http://dx.doi.org/10.1016/j.ebiom.2020.103085
work_keys_str_mv AT parkviviany expandingapplicationsofmribasedradiomicsinher2positivebreastcancer